ID: ALA5271745

Max Phase: Preclinical

Molecular Formula: C20H15ClFNO2

Molecular Weight: 355.80

Associated Items:

Representations

Canonical SMILES:  O=C(O)c1cc(F)cc(NCc2ccc(-c3ccc(Cl)cc3)cc2)c1

Standard InChI:  InChI=1S/C20H15ClFNO2/c21-17-7-5-15(6-8-17)14-3-1-13(2-4-14)12-23-19-10-16(20(24)25)9-18(22)11-19/h1-11,23H,12H2,(H,24,25)

Standard InChI Key:  VKYFIHRHBXLQNC-UHFFFAOYSA-N

Associated Targets(Human)

Peroxisome proliferator-activated receptor alpha 9197 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 355.80Molecular Weight (Monoisotopic): 355.0775AlogP: 5.46#Rotatable Bonds: 5
Polar Surface Area: 49.33Molecular Species: ACIDHBA: 2HBD: 2
#RO5 Violations: 1HBA (Lipinski): 3HBD (Lipinski): 2#RO5 Violations (Lipinski): 1
CX Acidic pKa: 4.46CX Basic pKa: 2.63CX LogP: 5.06CX LogD: 2.37
Aromatic Rings: 3Heavy Atoms: 25QED Weighted: 0.64Np Likeness Score: -1.12

References

1. Lee JJ, Hu Z, Wang YA, Nath D, Liang W, Cui Y, Ma JX, Duerfeldt AS..  (2023)  Design, Synthesis, and Structure-Activity Relationships of Biaryl Anilines as Subtype-Selective PPAR-alpha Agonists.,  14  (6): [PMID:37312852] [10.1021/acsmedchemlett.3c00056]

Source